Janssen Adopts J&J Name as Part of Global Rebranding Initiative

The renaming unites the medical technology and pharmaceutical segments under the Johnson & Johnson brand, driving innovation, leveraging synergies, and delivering better healthcare solutions worldwide.

Johannesburg, South Africa – November 2024

Johnson & Johnson has announced a significant update to its brand in South Africa, uniting its two business segments under the Johnson & Johnson name. This rebranding marks a pivotal step in the Company’s journey to advance healthcare solutions globally.

By aligning its pharmaceutical and medical technology segments under one umbrella, Johnson & Johnson aims to harness its expertise in innovative medicine and medtech to treat complex diseases with smarter, less invasive, and more personalised patient care.

Uniting as Johnson & Johnson

Moving forward:

• Janssen, the pharmaceutical segment, will be known as Johnson & Johnson Innovative Medicine.
• The medical technology segment will continue as Johnson & Johnson MedTech.

This global rebranding initiative, first announced in September 2023, positions the Company as a unified leader in healthcare innovation.

A Commitment to Innovation

Ahmed El Hofy, General Manager of Johnson & Johnson Innovative Medicine South Africa, remarked:
"We are excited to enter a new era of healthcare innovation. Though our name has changed, our purpose remains the same: to develop innovative treatments and champion patients every step of the way. Our commitment to South African patients, healthcare providers, and communities remains unwavering."

Focus Areas for Transformation

Johnson & Johnson Innovative Medicine will focus on advancing treatments in:

• Oncology
• Immunology
• Neuroscience
• Pulmonary Hypertension

By applying rigorous science and compassion, the Company aims to develop the breakthrough treatments of tomorrow.

Modernised Brand Identity

The updated Johnson & Johnson brand combines the Company’s legacy with a modern identity that reflects its commitment to inclusivity, healthcare innovation, and a compassionate approach.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation enables us to prevent, treat, and cure complex diseases, develop smarter, less invasive treatments, and deliver personalised solutions. Through expertise in Innovative Medicine and MedTech, we are uniquely positioned to deliver the healthcare breakthroughs of tomorrow and profoundly impact global health.

Press Release Submitted By

Contact Person: Annie Hodes
Phone: 083 325 4445
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Total Words: 312

---

Social Media Post

Johnson & Johnson Enters a New Era

Johnson & Johnson unites its pharmaceutical and medtech segments under one brand, driving innovation and delivering better healthcare solutions globally.

#JandJRebranding #InnovativeMedicine #MedTech #mypressportal #pressrelease #AfricaNewsroom #bizcommunity #publicrelations #africa #southernafrica #southafrica